Institutional Ownership
Xilio Therapeutics Inc
CUSIP 98422T209COMQ1 2026
Institutional Holders
20
13F filers
Shares Held
1.82M
Aggregate institutional
Institutional Value
$15.14M
Q1 2026
Net New Holders
+20
20 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions20
Increased0
Decreased0
Sold out0
Institutional Holders
20 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 664.0K | $5.58M | +664.0K | New |
| 2 | Frazier Life Sciences Management, L.P. | 422.5K | $3.55M | +422.5K | New |
| 3 | Sio Capital Management, LLC | 152.5K | $1.28M | +152.5K | New |
| 4 | Caligan Partners LP | 112.1K | $943.0K | +112.1K | New |
| 5 | Merck & Co., Inc. | 106.0K | $891.3K | +106.0K | New |
| 6 | Stonepine Capital Management, LLC | 64.2K | $539.6K | +64.2K | New |
| 7 | Morgan Stanley | 57.5K | $483.5K | +57.5K | New |
| 8 | Renaissance Technologies LLC | 49.6K | $416.9K | +49.6K | New |
| 9 | Aju Ib Investment Co., Ltd. | 47.7K | $401.1K | +47.7K | New |
| 10 | Geode Capital Management, LLC | 37.2K | $312.8K | +37.2K | New |
10 more institutional holders on Premium
See every fund holding Xilio Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders